A new diagnostic and an investigational eye-tracking technology for Parkinson's disease, ‘RightEye Vision System’ has been launched by RightEye.
The RightEye Vision System uses advanced eye-tracking technology/objective eye movement to help in the assessment of Parkinson's disease.
The eye-tracking system is designed to detect the ocular tremors that persist for patients with Parkinson's disease that do not allow the eyes to stabilize during gaze fixation.
This ability of the system might not only help in easing the process of diagnosis but could potentially and critically, allow for the earlier identification of the disease, as these ocular tremors often occur well before other symptoms.
The system, which is in the size of a laptop, also helps in the communication between provider and patient regarding its results by producing its results in an EyeQ report, a clearly organized, patient-friendly report featuring graphics and charts showing the opportunities recognized from the hundreds of collected metrics.
The device works by calibrating to every patient's eyes, then conducting a visual screening through saccades and pursuits which track every eye individually and provide analytics based on more than 1400 baseline metrics.
Diagnosing Parkinson's disease, a progressive nervous system disorder is difficult. By using the current methods of diagnosing Parkinson, physicians remain challenged by inaccuracy, making diagnosis an ongoing issue.
RightEye Vision System has received breakthrough device designation from US FDA for Parkinson's disease test.
